The Code Breaker profiles Jennifer Doudna, a Nobel Prize-winning biochemist key to the development of CRISPR, and examines the technology's exciting possibilities and need for oversight.
The latest advance is not only encouraging news for patients with severe combined immunodeficiency. It's a test case for all those scientists working to develop better gene therapy techniques.
Few scientific discoveries have caused as much excitement as that of editing our genes; yet we owe some of the most stunning wonders around us to old-fashioned breeding practices, says Jimena Canales.
